343 related articles for article (PubMed ID: 20068175)
1. Modulation of T-cell activation by malignant melanoma initiating cells.
Schatton T; Schütte U; Frank NY; Zhan Q; Hoerning A; Robles SC; Zhou J; Hodi FS; Spagnoli GC; Murphy GF; Frank MH
Cancer Res; 2010 Jan; 70(2):697-708. PubMed ID: 20068175
[TBL] [Abstract][Full Text] [Related]
2. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
3. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
4. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
[TBL] [Abstract][Full Text] [Related]
5. Antitumor immunity and cancer stem cells.
Schatton T; Frank MH
Ann N Y Acad Sci; 2009 Sep; 1176():154-69. PubMed ID: 19796244
[TBL] [Abstract][Full Text] [Related]
6. Detection of ABCB5 tumour antigen-specific CD8
Borchers S; Maβlo C; Müller CA; Tahedl A; Volkind J; Nowak Y; Umansky V; Esterlechner J; Frank MH; Ganss C; Kluth MA; Utikal J
Clin Exp Immunol; 2018 Jan; 191(1):74-83. PubMed ID: 28940439
[TBL] [Abstract][Full Text] [Related]
7. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
[TBL] [Abstract][Full Text] [Related]
8. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
[TBL] [Abstract][Full Text] [Related]
9. Tumor initiation in human malignant melanoma and potential cancer therapies.
Ma J; Frank MH
Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
[TBL] [Abstract][Full Text] [Related]
10. Isolation of tumorigenic circulating melanoma cells.
Ma J; Lin JY; Alloo A; Wilson BJ; Schatton T; Zhan Q; Murphy GF; Waaga-Gasser AM; Gasser M; Stephen Hodi F; Frank NY; Frank MH
Biochem Biophys Res Commun; 2010 Nov; 402(4):711-7. PubMed ID: 20977885
[TBL] [Abstract][Full Text] [Related]
11. Effects of Malignant Melanoma Initiating Cells on T-Cell Activation.
Schatton T; Schütte U; Frank MH
Methods Mol Biol; 2016 Jan; ():. PubMed ID: 26786883
[TBL] [Abstract][Full Text] [Related]
12. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients.
Wilson BJ; Schatton T; Zhan Q; Gasser M; Ma J; Saab KR; Schanche R; Waaga-Gasser AM; Gold JS; Huang Q; Murphy GF; Frank MH; Frank NY
Cancer Res; 2011 Aug; 71(15):5307-16. PubMed ID: 21652540
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.
Quintana E; Shackleton M; Foster HR; Fullen DR; Sabel MS; Johnson TM; Morrison SJ
Cancer Cell; 2010 Nov; 18(5):510-23. PubMed ID: 21075313
[TBL] [Abstract][Full Text] [Related]
14. Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.
Lin JY; Zhang M; Schatton T; Wilson BJ; Alloo A; Ma J; Qureshi AA; Frank NY; Han J; Frank MH
Biochem Biophys Res Commun; 2013 Jul; 436(3):536-42. PubMed ID: 23770371
[TBL] [Abstract][Full Text] [Related]
15. Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire.
Fourcade J; Sun Z; Kudela P; Janjic B; Kirkwood JM; El-Hafnawy T; Zarour HM
J Immunol; 2010 Jun; 184(12):6709-18. PubMed ID: 20483736
[TBL] [Abstract][Full Text] [Related]
16. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-melanoma interaction: role of surface molecules.
Becker JC; Bröcker EB
Recent Results Cancer Res; 1995; 139():205-14. PubMed ID: 7597291
[TBL] [Abstract][Full Text] [Related]
19. Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?
Lee N; Barthel SR; Schatton T
Lab Invest; 2014 Jan; 94(1):13-30. PubMed ID: 24126889
[TBL] [Abstract][Full Text] [Related]
20. Stem cells and targeted approaches to melanoma cure.
Murphy GF; Wilson BJ; Girouard SD; Frank NY; Frank MH
Mol Aspects Med; 2014 Oct; 39():33-49. PubMed ID: 24145241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
